Delayed
Sao Paulo
10:21:34 2024-05-16 am EDT
|
5-day change
|
1st Jan Change
|
5.31
BRL
|
+0.19%
|
|
-2.92%
|
-45.10%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,063
|
1,850
|
1,517
|
815.2
|
-
|
-
|
Enterprise Value (EV)
1 |
2,063
|
1,989
|
1,517
|
948.2
|
907.2
|
891.2
|
P/E ratio
|
-
|
12.6
x
|
15.7
x
|
4.48
x
|
4.66
x
|
3.94
x
|
Yield
|
0.68%
|
1.81%
|
-
|
3.5%
|
5.76%
|
10.4%
|
Capitalization / Revenue
|
2.4
x
|
2.17
x
|
2.01
x
|
0.89
x
|
0.74
x
|
0.66
x
|
EV / Revenue
|
2.4
x
|
2.34
x
|
2.01
x
|
1.03
x
|
0.83
x
|
0.72
x
|
EV / EBITDA
|
11.7
x
|
9.13
x
|
10.7
x
|
5.79
x
|
3.49
x
|
2.96
x
|
EV / FCF
|
-
|
33,913,358
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
157,354
|
156,529
|
156,573
|
153,808
|
-
|
-
|
Reference price
2 |
13.11
|
11.82
|
9.691
|
5.300
|
5.300
|
5.300
|
Announcement Date
|
3/16/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
858
|
851.2
|
756.1
|
919.9
|
1,095
|
1,231
|
EBITDA
1 |
176.1
|
217.9
|
141.7
|
163.8
|
259.6
|
300.8
|
EBIT
1 |
142.8
|
181.3
|
98.98
|
132.3
|
167.3
|
197.2
|
Operating Margin
|
16.65%
|
21.3%
|
13.09%
|
14.38%
|
15.27%
|
16.01%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
118
|
157.7
|
189.5
|
Net income
1 |
-
|
147.5
|
97.36
|
180
|
170.9
|
201.8
|
Net margin
|
-
|
17.33%
|
12.88%
|
19.57%
|
15.61%
|
16.39%
|
EPS
2 |
-
|
0.9364
|
0.6182
|
1.182
|
1.138
|
1.344
|
Free Cash Flow
|
-
|
58.66
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
6.89%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
26.92%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
39.78%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0891
|
0.2136
|
-
|
0.1854
|
0.3051
|
0.5532
|
Announcement Date
|
3/16/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
148.6
|
72.78
|
291.4
|
243.3
|
121.6
|
86.73
|
366.6
|
333.7
|
EBITDA
1 |
25.36
|
-18.56
|
90.13
|
49.94
|
6.824
|
-14.17
|
94.06
|
74.19
|
EBIT
1 |
-
|
-
|
-
|
33.24
|
-1.73
|
-20.47
|
84.67
|
65.09
|
Operating Margin
|
-
|
-
|
-
|
13.66%
|
-1.42%
|
-23.6%
|
23.09%
|
19.51%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
0.285
|
-24.18
|
82.45
|
58.1
|
Net income
1 |
-
|
-
|
-
|
-
|
0.8
|
-18.09
|
61.88
|
43.62
|
Net margin
|
-
|
-
|
-
|
-
|
0.66%
|
-20.86%
|
16.88%
|
13.07%
|
EPS
2 |
-
|
-
|
-
|
-
|
0.005700
|
-0.1272
|
0.4351
|
0.3067
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.1088
|
0.0767
|
Announcement Date
|
5/11/23
|
8/10/23
|
11/10/23
|
3/14/24
|
5/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
140
|
-
|
133
|
92
|
76
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.6407
x
|
-
|
0.812
x
|
0.3544
x
|
0.2527
x
|
Free Cash Flow
|
-
|
58.7
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
27.9%
|
27.9%
|
-
|
13.6%
|
21.1%
|
21.9%
|
ROA (Net income/ Total Assets)
|
-
|
16.3%
|
-
|
17%
|
18%
|
19%
|
Assets
1 |
-
|
902.1
|
-
|
1,059
|
949.6
|
1,062
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
61.3
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
7.2%
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/16/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Average target price
13.25
BRL Spread / Average Target +150.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -45.31% | 159M | | +19.22% | 39.82B | | -.--% | 11.27B | | +1.38% | 7.98B | | +4.24% | 6.66B | | -2.92% | 6.2B | | -2.13% | 5.88B | | +36.41% | 5.41B | | -13.81% | 5.39B | | +8.93% | 3.94B |
Other Agricultural Chemicals
|